Dundas Partners’s Bio-Techne TECH Stock Holding History

Dundas Partners’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-8,137	Closed	-$425K	–	49
2026 Q1	$425K	Sell	8,137 -1,799	-18%	-$108K	0.03%	35
2025 Q4	$584K	Hold	9,936	–	–	0.04%	34
2025 Q3	$553K	Buy	+9,936	New	+$532K	0.04%	35

Other funds holding TECH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

HBK Investments Dallas, Texas $10.3B AUM 67.69% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Dundas Partners's TECH Position: Q2 2026 in Review

Dundas Partners sold out of Bio-Techne (TECH) in Q2 2026, closing a stake of 8,137 shares — an estimated $425K sold.

Dundas Partners first reported a position in TECH in Q3 2025 and held it in 3 quarters. The position peaked at $584K in Q4 2025. 596 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

Dundas Partners reported no remaining Bio-Techne position as of Q2 2026 after selling out during the quarter.
Dundas Partners sold 8,137 Bio-Techne shares in Q2 2026, an estimated $425K.
Dundas Partners first reported a position in Bio-Techne in Q3 2025 and held it in 3 quarters.
Dundas Partners's Bio-Techne position peaked at $584K in Q4 2025.
596 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Dundas Partners's 13F filing for Q2 2026, filed 14 Aug 2026.